{"id":"W4402558709","doi":"10.1016/j.annonc.2024.08.2094","title":"2008P Assessing response durability and survival after second-line pembrolizumab in advanced urothelial carcinoma: A multicenter validation of a risk model","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Urothelial carcinoma; Oncology; Multicenter study; Carcinoma; Internal medicine; Cancer; Bladder cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01481116,0.0008108002,0.0008057046,0.0005244549,0.0003441845,0.0009744397,0.0009916051,0.0006420026,0.001879189],"category_scores_gemma":[0.02410053,0.0003052348,0.002086709,0.0004707315,0.0002604222,0.0005422881,0.0008785613,0.0009949153,0.0004400224],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0010994,"about_ca_system_score_gemma":0.001406985,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006231108,"about_ca_topic_score_gemma":0.003151036,"domain_scores_codex":[0.9968439,0.002272177,0.0000988264,0.0004059809,0.0002834322,0.00009559766],"domain_scores_gemma":[0.9844418,0.01046088,0.001815231,0.001950054,0.0009150144,0.0004169931],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03789424,0.002569706,0.7320862,0.0001919265,0.007202541,0.000205785,0.0002915707,0.0667102,0.003302796,0.0009115004,0.0106661,0.1379674],"study_design_scores_gemma":[0.006352956,0.01499614,0.4839837,0.00009253709,0.004739784,0.0006982906,0.0002261826,0.4745871,0.004851604,0.002389119,0.006977807,0.0001048759],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9780423,0.000364391,0.01399224,0.0007371375,0.00006771057,0.0004093787,0.00512475,0.0001839473,0.001078127],"genre_scores_gemma":[0.989532,0.00009253617,0.006519697,0.00009636887,0.00002914402,0.0002642033,0.002703599,0.00005531735,0.0007071491],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01481116,"threshold_uncertainty_score":0.0783298,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05517249742119814,"score_gpt":0.3924936933833818,"score_spread":0.3373211959621837,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}